Piero Montorsi

Showing 1-3 of 3 articles

Author Stefan Verheye

Coronary interventions

Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry

Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, Vrolix M, Buck T, Aminian A, van der Schaaf R, Arrif Nuruddin A, Lee MKY

January 22, 2019 | 10.4244/EIJ-D-18-01058

Author Daniela Trabattoni

Interventions for stroke

AMPLATZER versus Figulla occluder for transcatheter patent foramen ovale closure

Trabattoni D, Gaspardone A, Sgueglia G, Fabbiocchi F, Gioffrè G, Montorsi P, Calligaris G, Iamele M, De Santis A, Bartorelli A

April 20, 2017 | 10.4244/EIJ-D-15-00499

Author TC Aranzulla

Use of the Venture™ wire control catheter to access complex coronary lesions: how to turn procedural failure into success

Aranzulla T, Sangiorgi G, Bartorelli A, Cosgrave J, Corbett S, Fabbiocchi F, Montorsi P, Montorfano M, Trabattoni D, Colombo A

August 20, 2008

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke